Peramivir for severe influenza infection in a patient with diabetic nephropathy

American Journal of Respiratory and Critical Care Medicine

Volumn 182, Issue 9, 2010, Pages 1209-1210

  Nasu, Tatsuyo ^a   Ogawa, Daisuke ^a   Wada, Jun ^a   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; PERAMIVIR; ZANAMIVIR;

CYANOSIS; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPNEA; HUMAN; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; LETTER; PRIORITY JOURNAL; RESPIRATORY FAILURE; WORLD HEALTH ORGANIZATION;

EID: 78349242152     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/ajrccm.182.9.1209     Document Type: Letter

References (5)

1. United States Centers for Control and Prevention. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. (Accessed April 17, 2010.) Available from: http://www.cdc.gov/H1N1flu/recommendations.htm
2. Estenssoro E, Rios FG, Apezteguia C, Reina R, Neira J, Ceraso DH, Orlandi C, Valentini R, Tiribelli N, Brizuela M. Pandemic 2009 Influenza A (H1N1) in Argentina: a study of 337 patients on mechanical ventilation. Am J Respir Crit Care Med 2010;182:41-48.
3. Mauad T, Hajjar LA, Callegari GD, da Silva LF, Schout D, Galas FR, Alves VA, Malheiros DM, Auler JO Jr, Ferreira AF. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med 2010;181:72-79.
4. Kidd IM, Down J, Nastouli E, Shulman R, Grant PR, Howell DC, Singer M. H1N1 pneumonitis treated with intravenous zanamivir. Lancet 2009;374:1036.
5. Wiebe C, Reslerova M, Komenda P, Bueti J, Rigatto C, Sood MM. Atypical clinical presentation of H1N1 influenza in a dialysis patient. Lancet 2009;374:1300.